A carregar...
Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial
AIM: To assess the efficacy and safety of once‐daily ipragliflozin 50 mg versus placebo in Japanese people with type 1 diabetes mellitus (T1DM) inadequately controlled with insulin. MATERIALS AND METHODS: We conducted a multicentre, double‐blind, parallel‐group, placebo‐controlled phase 3 study. Par...
Na minha lista:
| Publicado no: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772182/ https://ncbi.nlm.nih.gov/pubmed/31173455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13807 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|